AT77317B - Process for the preparation of mercury solutions suitable for injection. - Google Patents

Process for the preparation of mercury solutions suitable for injection.

Info

Publication number
AT77317B
AT77317B AT77317DA AT77317B AT 77317 B AT77317 B AT 77317B AT 77317D A AT77317D A AT 77317DA AT 77317 B AT77317 B AT 77317B
Authority
AT
Austria
Prior art keywords
mercury
injection
preparation
succinimide
solutions suitable
Prior art date
Application number
Other languages
German (de)
Original Assignee
Chinoin Fabrik Chemisch Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Fabrik Chemisch Pharma filed Critical Chinoin Fabrik Chemisch Pharma
Application granted granted Critical
Publication of AT77317B publication Critical patent/AT77317B/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Description

  

   <Desc/Clms Page number 1> 
 



  Verfahren zur Herstellung von zu Injektionszwecken geeigneten Quecksilberlösungen. 
 EMI1.1 
 wart von Alkalien wasserlöslich. Der komplexen   Alkalisalzlösung   haftet jedoch hinwieder der Übelstand an, dass die Gegenwart des Alkalis bei der Einspritzung schmerzhaft wirkt, so dass diese nicht ohne Anwendung von anesthätischen Mitteln erfolgen kann, wobei trotzdem starke örtliche Reaktionen auftreten. 



   Wir haben nun gefunden, dass sich nicht nur die Quecksilberverbindung der Sulfe-   salizylsäure,   sondern auch anderer Sulfophenolkarbonsäuren oder   Phenoisutfosäuren   oder aber deren Halogensustitutionsprodukte, in Gegenwart von Succinimid in Wasser lösen und zwar ohne dass das Quecksilbersalz des Succinimides gebildet wird. 



   Succinimidquecksilber wurde schon für Injektionszwecke vorgeschlagen; obzwar diese Präparat bei der Injektion keine lokale Reaktion verursacht, hatte sich das Succinimidquecksilber wegen seiner leichten Zersetzlichkeit nicht eingeführt. 



   Aus den in Gegenwart von Succinimid   hergestellten Lösungen   lassen sich durch verdünnte Säuren wieder die ursprünglichen, schwer löslichen Quecksilberverbindungen ausfällen, woraus hervorgeht, dass das Quecksilber nicht als Succinimidquecksilber zugegen sein kann. 



   Da die in Gegenwart von Succinimid unter Vermeidung von Alkalien hergestellten
Lösungen der eingangs erwähnten Quecksilberverbindungen beim Einspritzen weder
Schmerzen noch örtlichen Reaktionen verursachen, äusserst beständig sind und das Queck- silber in maskierter Bindung enthalten, so eignen sie sich ganz hervorragend für Injektions-   zwecke@   
 EMI1.2 
 sich auch in Gegenwart von Succinimid nicht in Wasser mit Ausnahme des einfachen   Phenotquecksitbers,   das jedoch unter Bildung von gewöhnlichem Succinimidquecksilbar in Lösung geht, was gemäss der Erfindung gerade vermieden werden soll und durch die abweichende Konstruktion des Phenolquecksilbera erklärlich ist linen übergang bildet das maskierte Qecksilbersalz des   l'hlorpheno18,   welches sich,   wenn auch schwer   in Succinimid lÖst,

   doch ist die Lösung unbeständig und kommt   demnach   für den angestrebten Zweck nicht in Betracht. 
 EMI1.3 
 paraphenolsultosaures Natrium wird mit dem ein- bis zweifachen des molekulären Gewichtes Quecksilheracetat in   Wasserlösung gekocht,   wobei sich eine bisher nicht beschriebene, schwer lösliche dem sulfosalizylsauren Quecksilber entsprechende Quecksilber- Verbindung ausscheidet. 



     Der von uof Lösung   getrennte und gewaschene Niederschlag wird in 10 bis 15   Ge-   
 EMI1.4 
   angegeben, weiter behandelt. 



  Die ive avenge des Wassers und Succinimides kann je nach den Bedürfnissen geändert   werden. 

**WARNUNG** Ende DESC Feld kannt Anfang CLMS uberlappen**.



   <Desc / Clms Page number 1>
 



  Process for the preparation of mercury solutions suitable for injection.
 EMI1.1
 were water-soluble from alkalis. The complex alkali salt solution, however, has the disadvantage that the presence of the alkali during the injection is painful, so that this cannot take place without the use of anesthetic agents, whereby strong local reactions nevertheless occur.



   We have now found that not only the mercury compound of sulfosalicylic acid, but also other sulfophenol carboxylic acids or phenoisutfoic acids or their halogen substitution products, dissolve in water in the presence of succinimide and without the mercury salt of succinimide being formed.



   Succinimide mercury has been suggested for injection purposes; Although this preparation caused no local reaction when injected, succinimide mercury was not introduced because of its easy decomposition.



   The original, sparingly soluble mercury compounds can be precipitated again from the solutions prepared in the presence of succinimide by dilute acids, from which it can be seen that the mercury cannot be present as succinimide mercury.



   Since those produced in the presence of succinimide avoiding alkalis
Solutions of the mercury compounds mentioned at the beginning neither during injection
Pain still cause local reactions, are extremely persistent and contain the mercury in masked bond, they are ideal for injection purposes @
 EMI1.2
 not even in the presence of succinimide in water with the exception of the simple phenolic mercury, which, however, goes into solution with the formation of ordinary succinimide mercury, which according to the invention is to be avoided and can be explained by the different construction of the phenolic mercury l'hlorpheno18, which, although difficult to dissolve in succinimide,

   but the solution is inconsistent and therefore cannot be considered for the intended purpose.
 EMI1.3
 Sodium paraphenol is boiled in water solution with one to two times the molecular weight of mercury acetate, whereby a previously not described, sparingly soluble mercury compound corresponding to the sulphosalicylic acid is precipitated.



     The precipitate, separated from the solution and washed, is poured into 10 to 15
 EMI1.4
   specified, treated further.



  The ive avenge of the water and succinimides can be changed according to the needs.

** WARNING ** End of DESC field may overlap beginning of CLMS **.

 

Claims (1)

PATNET-ANSPRUCH: EMI1.5 **WARNUNG** Ende CLMS Feld Kannt Anfang DESC uberlappen**. PATNET CLAIM: EMI1.5 ** WARNING ** End of CLMS field may overlap beginning of DESC **.
AT77317D 1917-03-26 1917-03-26 Process for the preparation of mercury solutions suitable for injection. AT77317B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT77317T 1917-03-26

Publications (1)

Publication Number Publication Date
AT77317B true AT77317B (en) 1919-07-25

Family

ID=3598925

Family Applications (1)

Application Number Title Priority Date Filing Date
AT77317D AT77317B (en) 1917-03-26 1917-03-26 Process for the preparation of mercury solutions suitable for injection.

Country Status (1)

Country Link
AT (1) AT77317B (en)

Similar Documents

Publication Publication Date Title
AT77317B (en) Process for the preparation of mercury solutions suitable for injection.
DE453808C (en) Disinfectants
AT112734B (en) Process for the preparation of monocamphorates of the Solanaceae alkaloids.
AT138022B (en) Process for the preparation of hexamethylene hexamine hexajodide.
AT129764B (en) Process for the preparation of new water-soluble compounds of 2-phenylquinoline-4-carboxylic acid and its derivatives.
AT101337B (en) Process for the preparation of a basic bismuth salt of guaiacol-o-carboxylic acid.
AT122522B (en) Process for the preparation of water-soluble complex antimony salts of polyoxymonocarboxylic acids.
AT103715B (en) Process for the preparation of therapeutically effective preparations which contain combined glucosides and metals.
AT112135B (en) Process for the preparation of basic oxime ethers and their salts.
AT52837B (en) Process for the preparation of a new compound of m-cresol with oxalic acid.
AT59697B (en) Process for the preparation of a new yohimbine salt.
DE364883C (en) Process for the preparation of remedies against intestinal worms
AT123401B (en) Process for the preparation of 3.3&#39;-dichloro-4.4&#39;-dioxy-5.5&#39;-bisacylaminoarsenobenzenes.
DE552922C (en) Process for the preparation of a salt of 2,4-diaminoazobenzene
AT157699B (en) Method for the preparation of water-soluble organic mercury compounds.
AT152663B (en) Process for the preparation of an agent for disinfecting, wound treatment and the like. like
DE487868C (en) Manufacture of bleach and disinfectants
DE417973C (en) Process for the production of colloidal metal solutions
AT79679B (en) Process for the production of cold liquid glue.
AT243822B (en) Process for reducing the tendency for sodium chloride to cake
AT119480B (en) Process for the preparation of addition compounds of sulfur dioxide with aromatic p-diamines.
DE497909C (en) Process for the preparation of readily soluble salts of N-substituted benzimidazolonarsinic acids
DE944953C (en) Process for the preparation of a therapeutic agent consisting of the calcium salt of Ca-ethylene diamine tetraacetic acid
AT67784B (en) Process for the preparation of basic gallocarboxylic acid bismuth.
DE310213C (en)